eFFECTOR Therapeutics Inc.
www.effector.com
Latest From eFFECTOR Therapeutics Inc.
Pipeline Watch: Phase III Starts With Bavencio, MultiStem And VT-1161
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Finance Watch: Pfizer Ventures' Dalton Makes Sense Of Neuroscience Focus Within New $600m VC Fund Commitment
Venture Capital Edition: Pfizer deprioritized neuroscience as an early R&D focus earlier this year, but will stay involved by spending 25% of the $600m added to its venture fund on neurology investments. Also, China VC investment keeps up fast pace and Alta Partners closes a new $130m health care fund.
Biopharma Quarterly Deal-Making Statistics, Q2 2017
Biopharma companies raised $13.4 billion in Q2, mostly through IPOs. Thanks to several billion-dollar deals in Q2, 2017 is shaping up to be a year of CRO consolidations. Big pharma continued divesting assets to smaller biopharma companies.
eFFECTOR Translates $38.6m Into Five Cancer Clinical Trials
The firm's $38.6m in Series C cash will fund additional clinical trials for lead translation regulator eFT508, support the first human trial for eFT226 and advance a third program into preclinical studies.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- eFFECTOR Therapeutics Inc.
- Senior Management
-
Steve Worland, PhD, Pres. & CEO
Alana McNulty, CFO
Siegfried Reich, PhD, SVP, Research
Jeremy Barton, MD, CMO
Annette Matthies, PhD, VP, Corp. Dev. - Contact Info
-
eFFECTOR Therapeutics Inc.
Phone: (858) 925-8215
11180 Roselle St.
San Diego, CA 92121
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice